Plunkett Research Online: Amicus Therapeutics Inc

AMICUS THERAPEUTICS INC (FOLD:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Amicus Therapeutics, Inc. is a biopharmaceutical company that is focused on the discovery, development and commercialization of next-generation medicines for a range of rare and orphan diseases. Amicus focuses on improved therapies for lysosomal storage disorders (LSDs). Its lead product candidate.....



Amicus Therapeutics Inc
Ticker: FOLD
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 609 662-2000
Fax: 609 662-2001
Address: 1 Cedar Brook Drive
Cranbury, NJ 08512 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
John CrowleyCEO/Chairman of the Board/Director
William BairdCFO
See More
Amicus Therapeutics, Inc. is a biopharmaceutical company that is focused on the discovery, development and commercialization of next-generation medicines for a range of rare and orphan diseases. Amicus focuses on improved therapies for lysosomal storage disorders (LSDs). Its lead product candidate.....See More See More

Auditor: ERNST & YOUNG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Chaperone-Advanced Replacement Therapy (CHART)
migalastat HC1
Galafold
SD-101
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: